Swedbank Ab Castle Biosciences Inc Transaction History

Swedbank Ab

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Dec 09, 2024	SELL	$16.0 - $45.99 $560,000 - $1.61 Million	-35,000 Closed	0 $0
Q3 2021 Dec 09, 2024	SELL	$60.13 - $77.6 $300,650 - $388,000	-5,000 Reduced 12.5%	35,000 $2.33 Million
Q2 2021 Dec 09, 2024	BUY	$50.07 - $76.78 $250,350 - $383,900	5,000 Added 14.29%	40,000 $2.93 Million
Q1 2021 Dec 09, 2024	BUY	$58.92 - $97.33 $2.06 Million - $3.41 Million	35,000 New	35,000 $2.4 Million

202

26M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $779M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

Stay updated on Swedbank Ab with notifications on news.